{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:45:08Z","timestamp":1784720708124,"version":"3.55.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Colombiana de Psiquiatr\u00eda"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.rcp.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T18:30:50Z","timestamp":1497897050000},"page":"244-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Trastornos psiqui\u00e1tricos secundarios a enfermedades neurometab\u00f3licas"],"prefix":"10.1016","volume":"47","author":[{"given":"Paula M.","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"V\u00e9lez Van Meerbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bonnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcp.2017.05.004_bib0475","first-page":"55","article-title":"Orientaci\u00f3n diagn\u00f3stica de las enfermedades neurometab\u00f3licas basada en la cl\u00ednica, estudios metab\u00f3licos y neuroimagenol\u00f3gicos","volume":"73","author":"Campistol","year":"2013","journal-title":"Medicina (Buenos Aires)."},{"key":"10.1016\/j.rcp.2017.05.004_bib0480","first-page":"268","article-title":"Hiperamonemia en la edad pedi\u00e1trica Estudio de 72 casos","volume":"34","author":"P\u00e9rez","year":"2013","journal-title":"Acta Pediatr M\u00e9xico."},{"key":"10.1016\/j.rcp.2017.05.004_bib0485","series-title":"Temas de neuropediatr\u00eda","first-page":"105","article-title":"Patolog\u00eda neurometab\u00f3licas: formas de presentaci\u00f3n psiqui\u00e1trica","author":"Szlago","year":"2014"},{"key":"10.1016\/j.rcp.2017.05.004_bib0490","first-page":"365","article-title":"Psychiatric complications of a late diagnosis of acute porphyria in an affected male","volume":"32","author":"C\u00e1rdenas","year":"2009","journal-title":"Salud Mental."},{"key":"10.1016\/j.rcp.2017.05.004_bib0495","series-title":"Neurology and clinical neuroscience.","first-page":"223","article-title":"Schizophrenia and schizophrenia-like psychosis","author":"Price","year":"2003"},{"key":"10.1016\/j.rcp.2017.05.004_bib0500","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0033291700024922","article-title":"The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia","volume":"17","author":"Johnstone","year":"1987","journal-title":"Psychol Med."},{"key":"10.1016\/j.rcp.2017.05.004_bib0505","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1750-1172-9-65","article-title":"Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review","volume":"9","author":"Bonnot","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.rcp.2017.05.004_bib0510","first-page":"801","article-title":"Newborn screening for inherited metabolic disorders; news and views","volume":"18","author":"Pourfarzam","year":"2013","journal-title":"J Res Med Sci."},{"issue":"33 Suppl","key":"10.1016\/j.rcp.2017.05.004_bib0515","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eurpsy.2016.01.255","article-title":"Classical homocystinuria and psychiatric disturbances\u2014A case report","author":"Abreu","year":"2016","journal-title":"Eur Psychiatr."},{"key":"10.1016\/j.rcp.2017.05.004_bib0520","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ajmg.1320260427","article-title":"Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness","volume":"26","author":"Abbott","year":"1987","journal-title":"Am J Med Genet."},{"key":"10.1016\/j.rcp.2017.05.004_bib0525","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00431-015-2552-2","article-title":"Acute psychosis in an adolescent with undiagnosed homocystinuria","volume":"174","author":"Colafrancesco","year":"2015","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.rcp.2017.05.004_bib0530","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/003130299105025","article-title":"Homocystinuria and psychiatric disorder: a case report","volume":"31","author":"Li","year":"1999","journal-title":"Pathology."},{"key":"10.1016\/j.rcp.2017.05.004_bib0535","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/humu.22779","article-title":"Insights into severe 5, 10 methylenetetrahydrofolate reductase deficiency: molecular genetic and enzymatic characterization of 76 patients","volume":"36","author":"Burda","year":"2015","journal-title":"Hum Mut."},{"key":"10.1016\/j.rcp.2017.05.004_bib0540","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/318483","article-title":"MTHFR gene polymorphism and age of onset of schizophrenia and bipolar disorder","author":"El-Hadidy","year":"2014","journal-title":"BioMed Res Int."},{"key":"10.1016\/j.rcp.2017.05.004_bib0545","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00787-013-0449-z","article-title":"A forgotten lethal psychosis: a case report","volume":"23","author":"Mazzei","year":"2014","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0550","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1399-0004.2010.01391.x","article-title":"Molecular characterization of five patients with homocystinuria due to severe methylenetetrahydrofolate reductase deficiency","volume":"78","author":"Urreizti","year":"2010","journal-title":"Clin Genet."},{"key":"10.1016\/j.rcp.2017.05.004_bib0555","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1469-8749.2005.tb01040.x","article-title":"Folate induced reversal of leukoencephalopathy and intellectual decline in methylene tetrahydrofolate reductase deficiency: variable response in siblings","volume":"47","author":"Tallur","year":"2005","journal-title":"Develop Med Child Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwj347","article-title":"Methylenetetrahydrofolate reductase [MTHFR] genetic polymorphisms and psychiatric disorders: A HuGE review","volume":"165","author":"Gilbody","year":"2007","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0565","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bjo.55.5.338","article-title":"Review of four cases","volume":"55","author":"Homocystinuria","year":"1971","journal-title":"Br J Ophthalmol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0570","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","article-title":"Homocysteine levels in schizophrenia and affective disorders\u2014focus on cognition","volume":"8","author":"Moustafa","year":"2014","journal-title":"Front Behav Neurosci."},{"key":"10.1016\/j.rcp.2017.05.004_bib0575","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-3223(91)90174-K","article-title":"Clinical outcome and psychoendocrinological findings in a case of lethal catatonia","volume":"30","author":"Ferro","year":"1991","journal-title":"Biol Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0580","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12883-017-0827-0","article-title":"Rapidly progressive psychotic symptoms triggered by infection in a patient with methylenetetrahydrofolate reductase deficiency: a case report","volume":"17","author":"Iida","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0585","series-title":"GeneReviews\u00ae [Internet]. Seattle:","article-title":"Homocystinuria caused by cystathionine beta-synthase deficiency","author":"Picker","year":"2014"},{"key":"10.1016\/j.rcp.2017.05.004_bib0590","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0924-9338(97)89648-4","article-title":"Postoperative psychosis in homocystinuria","volume":"12","author":"Eschweiler","year":"1997","journal-title":"Eur Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0595","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0269881105048899","article-title":"Treatment of depression: time to consider folic acid and vitamin B12","volume":"19","author":"Coppen","year":"2005","journal-title":"J Psychopharmacol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0600","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-440X(97)90925-1","article-title":"Folate and cobalamin in psychiatric illness","volume":"38","author":"Hutto","year":"1997","journal-title":"Comprehens Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0605","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archneur.60.10.1457","article-title":"Neuropsychiatric disturbances in presumed late-onset cobalamin C disease","volume":"60","author":"Roze","year":"2003","journal-title":"Arch Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0610","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0735-6757(96)90097-2","article-title":"Ataxia, and altered mental status in an adolescent: late-onset ornithine transcarbamylase deficiency","volume":"14","author":"Myers","year":"1996","journal-title":"Am J Emerg Med."},{"key":"10.1016\/j.rcp.2017.05.004_bib0615","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","article-title":"Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update","volume":"106","author":"Patterson","year":"2012","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.rcp.2017.05.004_bib0620","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pediatrneurol.2012.08.012","article-title":"Developmental and psychiatric presentations of inherited metabolic disorders","volume":"48","author":"Turnacioglu","year":"2013","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0625","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00431-003-1347-z","article-title":"Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation","volume":"162","author":"Bachmann","year":"2003","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.rcp.2017.05.004_bib0630","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.spen.2008.05.007","article-title":"Neurologic damage and neurocognitive dysfunction in urea cycle disorders","volume":"15","author":"Enns","year":"2008","journal-title":"Sem Pediatr Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0635","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1176\/ajp.2007.164.7.1020","article-title":"Hyperammonemia due to valproic acid in the psychiatric setting","volume":"164","author":"Carr","year":"2007","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0640","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1258\/acb.2010.009250","article-title":"Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency","volume":"47","author":"Thurlow","year":"2010","journal-title":"Ann Clin Biochem."},{"key":"10.1016\/j.rcp.2017.05.004_bib0645","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2193-1801-2-13","article-title":"Valproic acid-induced hyperammonemic encephalopathy\u2014a potentially fatal adverse drug reaction","volume":"2","author":"Sousa","year":"2013","journal-title":"SpringerPlus."},{"key":"10.1016\/j.rcp.2017.05.004_bib0650","series-title":"Psychiatric features of epilepsy and their management The Treatment of Epilepsy","first-page":"273","author":"Elliott","year":"2009"},{"key":"10.1016\/j.rcp.2017.05.004_bib0655","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnins.2015.00177","article-title":"Secondary psychosis induced by metabolic disorders","volume":"9","author":"Bonnot","year":"2015","journal-title":"Front Neurosci."},{"key":"10.1016\/j.rcp.2017.05.004_bib0660","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ymgme.2016.10.005","article-title":"Acute intermittent porphyria in children: A case report and review of the literature","volume":"119","author":"Balwani","year":"2016","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.rcp.2017.05.004_bib0665","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/0006-3223(94)90085-X","article-title":"Varied psychiatric manifestations of acute intermittent porphyria","volume":"36","author":"Santosh","year":"1994","journal-title":"Biol Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197001000-00001","article-title":"Acute intermittent porphyria: a clinical and biochemical study of 46 patients","volume":"49","author":"Stein","year":"1970","journal-title":"Medicine."},{"key":"10.1016\/j.rcp.2017.05.004_bib0675","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1471-0528.1977.tb12480.x","article-title":"Pregnancy and the acute porphyrias","volume":"84","author":"Brodie","year":"1977","journal-title":"Int J Obstet Gynaecol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0680","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2008-1040701","article-title":"Neurologic manifestations of acute porphyria","volume":"2","author":"Bonkowsky","year":"1982","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.rcp.2017.05.004_bib0685","first-page":"1431","article-title":"High prevalence of intermittent acute porphyria in a psychiatric patient population","volume":"142","author":"Holbrook","year":"1985","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0690","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1016598207397","article-title":"A molecular, enzymatic and clinical study in a family with hereditary coproporphyria","volume":"25","author":"Gross","year":"2002","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.rcp.2017.05.004_bib0695","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MEJ.0b013e32830abe2e","article-title":"An unusual suicide attempt: a case with psychosis during an acute porphyric attack","volume":"16","author":"Altintoprak","year":"2009","journal-title":"Eur J Emerg Med."},{"key":"10.1016\/j.rcp.2017.05.004_bib0700","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0009-9236(99)70041-X","article-title":"Psychotropic drugs in acute intermittent porphyria","volume":"66","author":"Holroyd","year":"1999","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.rcp.2017.05.004_bib0705","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp.62.4.319","article-title":"The little imitator\u2014porphyria: a neuropsychiatric disorder","volume":"62","author":"Crimlisk","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0710","first-page":"1431","article-title":"High prevalence of intermittent acute porphyria in a psychiatric patient population","volume":"142","author":"Holbrook","year":"1985","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0715","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000289001","article-title":"Porphyria: reexamination of psychiatric implications","volume":"64","author":"Burgoyne","year":"1995","journal-title":"Psychother Psychosom."},{"key":"10.1016\/j.rcp.2017.05.004_bib0720","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/humu.20574","article-title":"Identification of novel ATP7B gene mutations and their functional roles in Korean patients with Wilson disease","volume":"28","author":"Park","year":"2007","journal-title":"Hum Mutat."},{"key":"10.1016\/j.rcp.2017.05.004_bib0725","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1469-1809.2001.6550459.x","article-title":"Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach","volume":"65","author":"Olivarez","year":"2001","journal-title":"Ann Hum Genet."},{"key":"10.1016\/j.rcp.2017.05.004_bib0730","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ejhg.2013.43","article-title":"The homozygosity index [HI] approach reveals high allele frequency for Wilson disease in the Sardinian population","volume":"21","author":"Gialluisi","year":"2013","journal-title":"Eur J Hum Genet."},{"key":"10.1016\/j.rcp.2017.05.004_bib0735","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1479-8301.2009.00282.x","article-title":"Pathogenesis and symptomatology of hallucinations [delusions] of organic brain disorder and schizophrenia","volume":"9","author":"Horiguchi","year":"2009","journal-title":"Psychogeriatrics."},{"key":"10.1016\/j.rcp.2017.05.004_bib0740","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/archpsyc.1989.01810120068011","article-title":"Wilson's disease: psychiatric symptoms in 195 cases","volume":"46","author":"Dening","year":"1989","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0745","first-page":"1","article-title":"Psychiatric symptoms of basal ganglia disorders: evaluation and management","volume":"12","author":"Marchand","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.rcp.2017.05.004_bib0750","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2007.09.009","article-title":"Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!","volume":"266","author":"Srinivas","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.rcp.2017.05.004_bib0755","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MD.0b013e318045a00e","article-title":"Wilson disease: description of 282 patients evaluated over 3 decades","volume":"86","author":"Taly","year":"2007","journal-title":"Medicine."},{"key":"10.1016\/j.rcp.2017.05.004_bib0760","first-page":"171","article-title":"Psychiatric and behavioral abnormalities in Wilson's disease","volume":"65","author":"Akil","year":"1995","journal-title":"Adv Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0765","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1440-1819.2002.01071.x","article-title":"Wilson's disease in psychiatric patients","volume":"56","author":"Stiller","year":"2008","journal-title":"Psychiatry Clin Neurosci."},{"key":"10.1016\/j.rcp.2017.05.004_bib0770","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1440-1819.2006.01592.x","article-title":"Wilson's disease asociated with delusional disorder","volume":"60","author":"Wichowicz","year":"2006","journal-title":"Psychiatry Clin Neurosci."},{"key":"10.1016\/j.rcp.2017.05.004_bib0775","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.neurol.2013.06.002","article-title":"Cognitive profile in Wilson's disease: a case series of 31 patients","volume":"169","author":"Wenisch","year":"2013","journal-title":"Rev Neurol (Paris)."},{"key":"10.1016\/j.rcp.2017.05.004_bib0780","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.psy.44.5.438","article-title":"Quetiapine for mania with Wilson's disease","volume":"44","author":"Kulaksizoglu","year":"2003","journal-title":"Psychosomatics."},{"key":"10.1016\/j.rcp.2017.05.004_bib0785","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: an update","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.rcp.2017.05.004_bib0790","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cgh.2013.03.012","article-title":"Efficacy and safety of oral chelators in treatment of patients with Wilson disease","volume":"11","author":"Weiss","year":"2013","journal-title":"J Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0795","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1176\/appi.ajp.2015.15030371","article-title":"The spectrum of psychiatric symptoms in Wilson's disease: treatment and prognostic considerations","volume":"172","author":"Zimbrean","year":"2015","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0800","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/B978-0-444-59565-2.00041-1","article-title":"Niemann-Pick diseases","volume":"113","author":"Vanier","year":"2013","journal-title":"Handb Clin Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0805","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awl260","article-title":"The adult form of Niemann-Pick disease type C","volume":"130","author":"Sevin","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.rcp.2017.05.004_bib0810","article-title":"Psychosis in an adolescent girl: a common manifestation in Niemann-Pick Type C disease","volume":"20","author":"Wouters","year":"2014","journal-title":"Child Adolesc Psychiatry Ment Health."},{"key":"10.1016\/j.rcp.2017.05.004_bib0815","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10545-013-9626-y","article-title":"Niemann-Pick type C Suspicion Index tool: analyses by age and association of manifestations","volume":"37","author":"Wraith","year":"2014","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.rcp.2017.05.004_bib0820","series-title":"Cholesterol use in autism treatment. Comprehensive guide to autism","first-page":"2403","author":"Diaz-Stransky Andrea","year":"2014"},{"key":"10.1016\/j.rcp.2017.05.004_bib0825","first-page":"785890","article-title":"Clinical and genetic characteristics of Mexican patients with juvenile presentation of Niemann-Pick Type C disease","volume":"2014","author":"Pi\u00f1a-Aguilar","year":"2014","journal-title":"Case Rep Neurol Med."},{"key":"10.1016\/j.rcp.2017.05.004_bib0830","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.spen.2014.04.012","article-title":"Cerebellar ataxia, vertical supranuclear gaze palsy, sensorineural deafness, epilepsy, dementia, and hallucinations in an adolescent male","volume":"21","author":"Tsao","year":"2014","journal-title":"Semin Pediatr Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0835","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/practneurol-2013-000525","article-title":"Niemann-Pick type C: a potentially treatable disorder?","volume":"13","author":"Kheder","year":"2013","journal-title":"Pract Neurol"},{"key":"10.1016\/j.rcp.2017.05.004_bib0840","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000002442","article-title":"Teaching Video NeuroImages: Vertical supranuclear ophthalmoparesis A diagnostic pearl for Niemann-Pick C","volume":"86","author":"Gupta","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.rcp.2017.05.004_bib0845","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1021\/cr990292q","article-title":"Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders","volume":"100","author":"Butters","year":"2000","journal-title":"Chem Rev."},{"key":"10.1016\/j.rcp.2017.05.004_bib0850","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10072-006-0618-7","article-title":"Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene","volume":"27","author":"Gallus","year":"2006","journal-title":"Neurol Sci."},{"key":"10.1016\/j.rcp.2017.05.004_bib0855","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1468-1331.2011.03439.x","article-title":"Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey","volume":"18","author":"Pilo de la Fuente","year":"2011","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0860","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymgme.2015.10.010","article-title":"Apparent underdiagnosis of cerebrotendinous xanthomatosis revealed by analysis of\u223c 60,000 human exomes","volume":"116","author":"Appadurai","year":"2015","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.rcp.2017.05.004_bib0865","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s11011-016-9841-y","article-title":"Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports","volume":"31","author":"Di Taranto","year":"2016","journal-title":"Metab Brain Dis."},{"key":"10.1016\/j.rcp.2017.05.004_bib0870","first-page":"42","article-title":"Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds","volume":"27","author":"Moghadasian","year":"2004","journal-title":"Clin Invest Med."},{"key":"10.1016\/j.rcp.2017.05.004_bib0875","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-014-0179-4","article-title":"Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management","volume":"9","author":"Nie","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.rcp.2017.05.004_bib0880","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.chc.2013.04.004","article-title":"Congenital and acquired disorders presenting as psychosis in children and young adults","volume":"22","author":"Sheldon","year":"2013","journal-title":"Child Adolesc Psychiatr Clin North Am."},{"key":"10.1016\/j.rcp.2017.05.004_bib0885","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1038\/tp.2013.76","article-title":"Psychiatric manifestations in cerebrotendinous xanthomatosis","volume":"3","author":"Fraidakis","year":"2013","journal-title":"Translat Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0890","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nrl.2010.12.009","article-title":"Utilidad de los niveles de colestanol en el diagn\u00f3stico y seguimiento de los pacientes con xantomatosis cerebrotendinosa","volume":"26","author":"De la Fuente","year":"2011","journal-title":"Neurologia."},{"key":"10.1016\/j.rcp.2017.05.004_bib0895","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/WNF.0b013e318288076a","article-title":"Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis","volume":"36","author":"Yahalom","year":"2013","journal-title":"Clin Neuropharmacol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0900","first-page":"55","article-title":"Psychiatric emergencies (part I): psychiatric disorders causing organic symptoms","volume":"17","author":"Testa","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1016\/j.rcp.2017.05.004_bib0905","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000338548","article-title":"Early-onset schizophrenia","volume":"66","author":"Remschmidt","year":"2012","journal-title":"Neuropsychobiol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0910","first-page":"1","article-title":"Adverse childhood experiences among inpatient youths with severe and early-onset psychiatric disorders: prevalence and clinical correlates","author":"Benarous","year":"2016","journal-title":"Child Psychiatry Hum Dev."},{"key":"10.1016\/j.rcp.2017.05.004_bib0915","series-title":"22q11.2 deletion syndrome: a paradigmatic copy-number-variant (CNV) disorder Health care for people with intellectual and developmental disabilities across the lifespan","first-page":"723","author":"Cubells","year":"2016"},{"key":"10.1016\/j.rcp.2017.05.004_bib0920","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.67.6.803","article-title":"Psychiatric inpatients and chromosome deletions within 22q11.2","volume":"67","author":"Sugama","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.rcp.2017.05.004_bib0925","series-title":"Considering organic pathology. The Psychiatric Interview for Differential Diagnosis","first-page":"109","author":"Jansson","year":"2016"},{"key":"10.1016\/j.rcp.2017.05.004_bib0930","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/JCP.0b013e3182549259","article-title":"Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis","volume":"32","author":"Cohen","year":"2012","journal-title":"J Clin Psychopharmacol."},{"key":"10.1016\/j.rcp.2017.05.004_bib0935","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/cpt.134","article-title":"Metabolomic signatures for drug response phenotypes: pharmacometabolomics enables precision medicine","volume":"98","author":"Kaddurah Daouk","year":"2015","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.rcp.2017.05.004_bib0940","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5498\/wjp.v4.i4.69","article-title":"Neuropsychiatric genetics in developing countries: current challenges","volume":"4","author":"Forero","year":"2014","journal-title":"World J Psychiatry."}],"container-title":["Revista Colombiana de Psiquiatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034745017300604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034745017300604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T12:21:12Z","timestamp":1538396472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034745017300604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0034745017300604"],"URL":"https:\/\/doi.org\/10.1016\/j.rcp.2017.05.004","relation":{},"ISSN":["0034-7450"],"issn-type":[{"value":"0034-7450","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trastornos psiqui\u00e1tricos secundarios a enfermedades neurometab\u00f3licas","name":"articletitle","label":"Article Title"},{"value":"Revista Colombiana de Psiquiatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcp.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asociaci\u00f3n Colombiana de Psiquiatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}